The Peptide CommonsEst. May 2024
Independent. We sell nothing and are affiliated with no manufacturer or pharmacy. Every moderation action is logged in public
SF

s.ferreira

TL2 Moderator · Coimbra

Contributes reviews on supplier material. Based in Coimbra.

Joined 19 October 2024 · last posted 1d

91Posts here
1Topics
0Solutions
132Likes received
113Likes given
20Badges
58Days visited
651Posts read

Most-liked posts

  • Reimbursement variation across member states Started this topic · Regional › European Union · 29 Apr 2026 · 41 likes Reimbursement variation across member states Writing it up because I had to work it out twice and would rather nobody else did. A coverage question with the paperwork…
  • Asking a follow-up: new topic or new reply? Replied, post #45 · Start Here › How to Ask · 9 Jul 2026 · 32 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
  • Second pass at: Cross-border purchase within the EU: the actual rules Replied, post #43 · Access › International · 14 Feb 2025 · 32 likes This follows post #40 rather than contradicting it. Country-by-country legality: compound approval and legal status differ substantially by jurisdiction. Semaglutide…
  • The 2.5 mg starting dose is not a therapeutic dose — why that matters Replied, post #18 · Compounds › Tirzepatide · 17 Feb 2026 · 30 likes I read post #16 twice before replying, because I had assumed the opposite. Two things before anyone answers the substance. First, the context in the first post is clear…
  • Asking about a compound your prescriber has not heard of Replied, post #135 · Clinical › Prescriber conversations · 23 Aug 2025 · 30 likes Worth separating two things that post #131 runs together. Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did…
  • Journal club: is percentage weight change the right endpoint? Replied, post #97 · Evidence › Journal club · 23 Apr 2026 · 29 likes Picking up post #94: that is the part I would want checked first. SURMOUNT-1 (N Engl J Med 2022): Tirzepatide obesity trial. The largest mean weight reduction for a…

Where this member posts

CategoryPostsShare
Practice1112%
Analytics1011%
Compounds1011%
Evidence78%
Sourcing78%
Start Here67%

Badges earned, in order

BadgeTierGranted
Basic Userbronze22 Oct 2024
First Replybronze22 Oct 2024
Read the Guidelinesbronze24 Oct 2024
Asked Wellbronze26 Oct 2024
Welcomebronze27 Oct 2024
First Linkbronze1 Nov 2024
First Topicbronze9 Nov 2024
First Quotebronze28 Nov 2024
First Tagbronze29 Nov 2024
Sourcedbronze5 Dec 2024
Memberbronze16 Dec 2024
Editorbronze22 Jan 2025
Readerbronze13 Feb 2025
Nice Postbronze2 May 2025
Nice Topicbronze3 May 2025
Good Postsilver16 May 2025
De-escalatorgold16 May 2025
Good Topicsilver28 Jun 2025
Promotedsilver11 Jul 2025
Anniversarysilver19 Oct 2025